Protease-activatable retroviral vectors offer the possibility of targeted gene transfer into cancer cells expressing a unique set of proteases as, for example, the matrix metalloproteases (MMPs). However, it is difficult to predict which substrate sequence will be optimally cleaved by a given tumour cell type. Therefore, we developed a novel approach that allows the selection of MMP-activatable retroviruses from libraries of viruses displaying combinatorially diversified protease substrates. Starting from a virus harbouring a standard MMP-2 substrate motif, after only two consecutive cycles of diversification and in vivo selection, MMP-activatable viruses were recovered. Biochemical characterization of the selected viruses revealed that their linker peptides showed a considerably increased sensitivity for MMP-2 cleavage, and interestingly also improved the particle incorporation rate of the Env protein. Owing to the optimized linker peptide, the selected viruses exhibited a greatly enhanced spreading efficiency through human fibrosarcoma cells, while having retained the dependency on MMP activation. Moreover, cell entry efficiency and virus titres were considerably improved as compared to the parental virus displaying the standard MMP-2 substrate. The results presented imply that retroviral protease substrate libraries allow the definition of MMP substrate specificities under in vivo conditions as well as the generation of optimally adapted tumour-specific viruses.
Introduction
Targeted gene transfer into the patient's cells of interest are among the major challenges in current vector development for gene therapy strategies. For suicide gene transfer or virotherapy, targeting at the level of cell entry is of special interest as it assures efficient transfer and a low risk for side effects. 1 For retroviral vectors, a number of different strategies have been developed during the past years. 2, 3 Among the initial strategies was the host range extension to specific human cells of murine retroviruses. For this purpose, the envelope (Env) proteins of the ecotropic Moloney murine leukaemia virus (MoMLV) had been covalently modified with antibody fragments (scFvs) directed against human cell surface antigens. Although this resulted in redirected binding of the vector particles to human cells, cell entry and gene transfer were usually inefficient. [4] [5] [6] However, alternative targeting strategies for retroviruses like, for example, collagen binding, 7 bi-specific adaptor molecules, 8 or protease activatable vectors have been developed. 9, 10 In the latter approach, cell entry of the virus particles depends on the types of proteases expressed by a given cell type. 11 This is achieved by displaying blocking domains via protease cleavable linker peptides on MLV Env proteins. 2, 12 Retroviral Env proteins are homotrimers composed of heterodimers formed by the surface unit (SU) that contacts the viral receptor during cell entry and the transmembrane unit (TM) that anchors the Env protein complex in the viral envelope. The SU and TM proteins arise from intracellular proteolytic cleavage of a single Env precursor protein. Growth factor receptor ligands fused to the N-terminus of the SU protein reduce infectivity on receptor-positive target cells by sequestering the virus onto the targeted receptor, thereby preventing it from interacting with its natural receptor. 4 Thus, vectors engineered to display epidermal growth factor (EGF) exhibit a low infectivity on EGF receptor overexpressing tumour cell lines like HT1080 or A431, but are unimpaired in the infection of cell lines low in EGF receptor levels. However, if linker peptides cleavable by, for example, factor Xa, plasmin, or matrix metalloproteases (MMPs) were inserted, infectivity can be restored on cells that express high levels of EGF receptor and that are positive for the targeted protease. [11] [12] [13] MMPs currently form a family of 28 members that are responsible for destruction of the extracellular matrix (ECM) and mediate invasion of tumour cells into tissue by degradation of the ECM. [14] [15] [16] Multiple MMP family members, like collagenase 1 (MMP-1), gelatinases A (MMP-2) and B (MMP-9), matrilysin (MMP-7), and the membrane-type (MT)-MMPs have been correlated with tumour progression. 15, 17 They concentrate on tumour cell membranes, especially at the invasive front of the tumour. 14 For its activation, MMP-2 associates with tissue inhibitors of MMPs (TIMP) before its propeptide is cleaved off by MT1-MMP. 15 In view of the complexity of the proteolytic machinery that degrades the ECM during metastasis on one hand, and its accessibility determined by the architecture of the viral envelope on the other, it is almost impossible to envisage readily what could be the most potent linker peptide for a given cancer cell type. Therefore, an appealing strategy is to select viruses with optimal cleavage signals from virus libraries differing by their linker peptides under physiological relevant conditions, thereby taking the diversity of MMP-types involved into account.
To that end, we have established the methodology of retroviral substrate libraries and designed a strategy for the selection of protease cleavage sites. 10 This first generation of libraries was established by inserting fully randomized linker peptides between the EGF blocking domain and the ecotropic MoMLV-derived Env protein.
When this library was selected on an HT1080 cell clone expressing the MoMLV receptor, cleavage sites for intracellular furin-like proteases and proprotein convertases (PC) were exclusively selected. 10 However, none of the selected viruses displayed a cleavage site fulfilling known consensus motifs of MMPs, which are overexpressed on HT1080 cells. Thus, to achieve the selection of viruses that are activated by proteases specifically expressed on tumour tissue, like MMPs, virus activation by ubiquitously expressed proteases has to be prevented.
Here, we present a second generation of retroviral peptide libraries which allowed the selection of MMPactivatable viruses in HT1080 cells. These are based on amphotropic MLV, thus enabling selection on tumour cells of human origin. More importantly, key residues in the MMP-cleavable linker peptide were randomized such that the inadvertent introduction of furin or PC cleavage signals could be avoided. Two consecutive rounds of library design and in vivo selection resulted in MMP-activatable retroviruses with considerably enhanced spreading efficiencies on tumour cells.
Results

Generation and selection of the libraries
To generate the second generation of retroviral protease substrate libraries, the Env protein reading frame in plasmid pE-Mo was substituted against the env gene of the amphotropic 4070A MLV, thus generating plasmid pE-A and extending the host range of the encoded virus to human cells (Figure 1 ). Efficient blocking of the EGF domain in context of the 4070A MLV Env was previously demonstrated. 11 This was used as parental plasmid to generate the libraries and the plasmid pE-MMP-A, which encodes an EGF-blocked virus with the linker peptide PLGkLWA previously shown to be cleaved by MMP-2 and MT1-MMP at highest efficiencies. 18, 19 In this peptide cleavage occurs between the G and L residues, thus defined as P1 and P1 0 positions, respectively. The residues following N-terminally of P1 and C-terminally of P1 0 are numbered according to their order. In the library pE-X3-A, we diversified the P2, P2', and P3' positions of the six residues of the MMP-2 cleavage site, but kept the P1 and P1 0 residues constant ( Figure 1 ). To prevent the selection of serine protease cleavage sites arginine and in the P2 0 position also lysine residues were excluded by using degenerated doping codons. 20 The codons were combined such that the PLGLWA cleavage site present in the E-MMP-A virus was included in the library. In total, the E-X3-A library consists out of about 3500 different sequence variants, which were well covered by the 10 7 bacterial clones obtained. For selection, the human fibrosarcoma cell line HT1080 was transfected with the pE-X3-A library at an estimated transfection efficiency of 5%. The transfected cells were then expanded until day 8 when an equal amount of uninfected HT1080 cells was added. Selection of the virus population was completed by day 14 when RT activity became detectable in the cell supernatant. To follow the selection process, linker peptide sequences present in the virus population were determined at days 2, 6, and 14 after transfection.
The frequencies of each possible amino-acid residue at each of the three diversified positions, respectively, are listed in Figure 2a . Although we cannot completely rule out that the scissile bond in the selected peptides has changed the standard substrate residue nomenclature as given for the PLGLWA peptide will be used for simplicity. At day 2, the amino-acid residues are randomly distributed, no preferential selection for any residue at any of the three positions is evident. Also, at day 6, the distribution seems to be random, albeit tyrosine residues seemed to be slightly over-represented at the P2 0 position. This tendency became highly significant in the virus population harvested at day 14. Then, at each of the diversified positions, a clear preference for certain specific residues was evident. As P2 residue: glutamine was selected in almost 70% of the linker peptides sequenced, while tyrosine was the most prominent P2 0 residue. The P3 0 position seems to be less crucial, as here glutamine or lysine and at a lower frequency also alanine was selected by the viruses. These In Table 1 , the sequences of the selected peptides are listed together with their relative frequencies of occurrence. Also, data obtained from a complete repetition of the selection procedure are presented. In both selections, the most frequent peptide types were identical, confirming the reproducibility of the approach. At least half of the viruses present in the populations after selection encoded linker peptides with glutamine or (rarely) lysine in the P2, and tyrosine or phenylalanine in the P2 0 positions. Of these peptides by far the majority contained lysine or glutamine in the P3 0 position, a few also alanine or serine. The third motif obtained at considerable frequency in both selections is distinguished by small amino acids, namely alanine or serine replacing the aromatic residues in the P2 0 position. Apart from these prominent motifs more than 10 other types of peptides were selected, but, at low frequencies below 10%, indicating that these were less valuable for the virus to grow. Thus, PQGLYK/Q can be recorded as the consensus for the most frequently selected peptides.
Besides determining the linker peptide sequences, we also checked the occurrence of any sequence alterations N-and C-terminally of the linker peptides. A single mutation was observed, that is, a G to A transition resulting in a stop codon at the 5 0 -end of the EGF reading frame, thus preventing expression of the env gene. This mutation occurred at a frequency of 10-20% of the selected viruses, notably after selection of both the E-X3-A and the E-X3rev-A library. As each retrovirus particle encapsidates two copies of its genome, the mutant genome was probably carried over as a 'satellite' sequence alongside the functional genomes. Although the relevance of this mutation is currently unclear, the relatively high frequency suggests that the mutant genome was beneficial for the virus population. The linker peptides encoded by the mutant genomes were not included in Tables 1 and 2 , although the majority was of the most frequently selected peptide type.
We next addressed the question if the P, G, and L residues that were kept constant in the E-X3-A library were optimal for efficient virus growth in context of the residues selected at highest frequency. For this purpose, the E-X3rev-A library was generated, in which we fixed P2 with glutamine, P2' with tyrosine and allowed alanine or glutamine in P3' (Figure 1 ). The other three residues including the P1 and P1 0 positions were diversified, resulting in a library covering about 50 000 combinations on the DNA level and about 5000 peptide combinations, a complexity that was well covered by the 10 6 bacterial clones obtained. Sequence analysis of the virus library present in the supernatant of HT1080 cells 2 days after transfection demonstrated the random distribution of amino-acid residues at each of the diversified positions ( Figure 2b) . As for the E-X3-A library, RT activity increased after starting the cocultivation with uninfected HT1080 cells. By day 14, virus was harvested, cloned and the linker peptide sequences determined. Clear preferences for proline at P3, glycine at P1, and mainly leucine but also isoleucine in P1' were obvious (Figure 2b ). All the linker peptide sequences are listed in Table 2 . In almost half of the peptides proline at P3 and glycine at P1 were selected. Moreover, in the P1' site, leucine occurred most frequently, with the homologous isoleucine and valine also being common. In another 25% of the selected peptides, identical or homologous residues appeared in 
a Diversified positions are depicted in bold. Several residues at one position are listed in the order of their observed frequencies.
Directed evolution of targeted retroviruses RM Schneider et al the P1 and P1' positions, while the P3 position was occupied by other hydrophobic residues than proline. Thus, in total about 70% of the peptides selected from the E-X3rev library were homologous or even identical to those selected from the E-X3 library. The remaining 12 peptides occurred only once.
Selected linker peptides are cleaved by MMP-2
Our selection procedures suggested that peptides of the PQGLY(A/Q)-type must be the most efficient variants for virus growth on HT1080 cells. To prove this, we reconstituted the viruses E-21-A and E-26-A with the linker peptides PQGLYA and PQGLYQ, respectively, and compared these with the parental E-MMP-A virus and the E-A virus displaying EGF via a noncleavable linker. At first, we asked if the selected linker peptides served as protease cleavage site and which protease might be responsible. HT1080 cells are known to secrete high levels of MMP-2 while HEK-293T cells should be free of MMP-2. 11, 21 We analysed our HEK-293T, HT1080, and also A431 cells by gelatine zymography of conditioned culture medium harvested from the cell lines. In agreement with the published data, we detected the highest levels of active MMP-2 in the culture fluid of HT1080 cells, only low activity in A431 cells and no activity in HEK-293T cells (not shown), suggesting that MMP-2 might activate the selected viruses.
In a first step, we followed the processing of the viral Env proteins in the MMP-negative HEK-293T cells, which are low in EGF receptor expression (determined by FACS; data not shown) and therefore allows free replication of the viruses. In cell extracts, we found two bands for all of the EGF-modified viruses. Of these, the upper band corresponds to the EGF-SU-TM precursor protein, while the lower band migrates slightly above the wild type SU protein and thus reflects the EGF-SU protein ( Figure 3a, upper panel) . Interestingly, the relative amount of the processed EGF-SU protein as compared to the EGF-SU-TM precursor was reproducibly higher in cells infected with the selected viruses than in cells infected with the parental E-MMP-A virus (lanes 5, 6 and lane 4). We then harvested virus particles from the supernatant of HEK-293T cells and treated the viral proteins with PNGase F before Western blot analysis to facilitate the separation of the EGF-SU from the SU protein. For both selected viruses as well as the parental virus only the EGF-SU protein was detectable, demonstrating that no proteolytic activity is present in HEK-293T cells that allows cleavage of the linker peptides ( Figure 3a , bottom panel). 
b Hy stands for pro, phe, leu, ala, ile.
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Interestingly, the amounts of EGF-SU incorporated into the particles differed among the virus types. When normalized to the p30 signals, the incorporation rates of the selected Env proteins were five-(E-21-A) or even 10-fold (E-26-A) higher than for the E-MMP-A virus ( Figure  3b ). This corresponded to a 2.0 (E-21-A) and 2.2 (E-26-A) fold increased cell surface expression efficiency as determined by FACS analysis using an anti-EGF monoclonal antibody, respectively (not shown).
Next, we analysed the proteolytic processing of the Env proteins in the MMP-positive HT1080 cells. Here, in contrast to HEK-293T cells (450%) only a low transfection efficiency of about 5% was reached so that virus spreading contributed to the signal intensities obtained. While the Env proteins of the selected viruses were easily detectable, cells infected with the E-A or E-MMP-A virus contained no or only very low amounts of Env protein ( Figure 3c, lanes 2, 3) . In contrast to particles released from HEK-293T cells, the E-21-A and the E-26-A particles released from HT1080 cells contained two types of SU proteins corresponding in size to the EGF-SU (Figure 3c compare lanes 9, 10 to lane 7) and the SU protein (compare lanes 9, 10 with lane 6). Based on the relative intensities of both bands, the EGF domain had been cleaved off from about two-thirds of the SU proteins. Taken together, these data demonstrate that the linker peptides of the selected viruses are cleaved by a protease expressed by HT1080 cells but not by HEK-293T cells. Moreover, the Env proteins containing the selected linker peptides are more efficiently transported to the cell surface and incorporated into virus particles than the parental Env protein.
To test if MMP-2 is in fact able to cleave the selected linker peptides, we incubated virus particles released from HEK-293T cells with MMP-2 and followed the proteolytic activity by Western blot analysis. Figure 4a shows that the EGF domain was efficiently removed from the SU proteins of the E-26-A virus and of the E-MMP-A virus (lanes 5, 7). As the EGF-SU protein of the E-A virus remained unchanged upon MMP-2 treatment, cleavage must have occurred within the linker peptides (lane 3). While the E-26-SU protein was completely digested, a significant amount of E-MMP-SU protein was still detectable after digestion, indicating that the PQGLYQ peptide was more efficiently cleaved than the PLGLWA peptide.
In order to show conclusively that the selected PQGLYQ peptide was cleaved by MMP-2, we transferred this as well as the parental linker peptide into the context of another blocking domain, the extracellular domain of CD40L, giving rise to constructs C-26-A and C-MMP-A ( Figure 1 ). As control, a virus with a noncleavable Env protein was also generated (C-A). As before, HEK-293T cells were transfected with plasmids encoding the viruses, virus particles were harvested from the cell culture supernatant and subjected to MMP-2 digestion. While the electrophoretic mobility of the C-A Env protein remained unchanged, cleavage of the C-MMP-A Env, although at low efficiency, was detectable. In contrast, the CD40L domain of the selected C-26-A Env protein was removed from about half of the molecules (Figure 4b) . Thus, also in the context of another blocking domain the PQGLYQ linker peptide is being cleaved by MMP-2 and again, at a considerably higher efficiency than the parental PLGLWA peptide. By staining the blots against p30, we also estimated the Env-incorporation rates for the CD40L displaying viruses. Noteworthy, and in constrast to the EGF displaying viruses, the incorporation levels in presence of the parental linker peptide and the selected linker peptide PQGLYQ were similar (shorter exposure of Figure 4b , not shown). Thus, enhanced incorporation was observed only in context of the EGF polypeptide while enhanced MMP-2 cleavage occurred in the context of both types of blocking domains.
To further compare the MMP-2 sensitivities of PQGLYA and PLGLWA, we performed kinetic cleavage studies. After 5 min of MMP-2 treatment, cleavage of both linker peptides was observed. Densitometric analysis revealed that 65% of the EGF-SU protein was (Figure 4c, lanes 2, 7) . Also after 20 min more of the selected linker peptide was cleaved (93 versus 70%), while after 40 min unspecific degradation of the proteins was observed (lanes 3, 4 and 8, 9). When we reduced the amounts of MMP-2 to half, the difference in the substrate conversion rates became even more profound. Then, a 3.5-fold difference in cleavage efficiency was observed (not shown). These experiments demonstrate that the selected viruses can be activated by MMP-2 and that their linker peptides are more efficiently converted by MMP-2 than that of the parental virus.
Enhanced spreading of the selected viruses in HT1080 cells
To compare the growth characteristics of the reconstituted selected viruses with the parental virus, stocks of these viruses were produced on HEK-293T cells and then used to infect HT1080 cells at a low multiplicity of infection (MOI). We then followed spreading of the viruses by immunostaining of the infected cells and by assaying reverse transcriptase (RT) activity released into the cell culture supernatant. After 72 h p.i. virus particles released from the primarily infected cells had spread into neighbouring cells so that in case of the E-MMP-A, E-26-A, and E-21-A viruses foci became visible, whereas no spreading was observed for the E-A virus (Figure 5a) . Interestingly, the shapes of the foci differed significantly between the selected viruses and the E-MMP-A virus. The selected viruses formed very dense, compact foci that were even macroscopically clearly visible, suggesting a rapid spreading of the viruses from the infected cell to the neighbouring cells (bottom panels). In contrast, foci derived from the E-MMP-A virus infection exhibited a less dense appearance with the infected cells being more separated from each other. In fact: at the same time point the E-MMP-A-derived foci included only about half of the number of infected cells observed with the selected viruses (top right and bottom panels). In agreement with this, RT units released from cells infected with the E-21-A or E-26-A virus were initially similar to that of E-MMP-A-infected cells, however, from about 50 h p.i., increased more rapidly (Figure 5b) . By day 5, the selected viruses had spread into about 50% of the cells in the culture dish, whereas only about 10% of the cells had become infected with the parental E-MMP-A virus (Figure 5c ). Finally, the selected viruses had achieved complete infection of the cell layer by day 9. Then, the number of infectious particles released from the cells was remarkably 1000-fold higher than that detected in the supernatant of E-MMP-A-infected cells (Figure 5c ). Western blot and also RT-PCR analysis of these viral particles confirmed that the selected viruses had retained the EGF reading frame in their genome and thus were genetically stable (data not shown).
The selected viruses are MMP dependent and show enhanced cell entry
The experiments described above demonstrated that the selected viruses spread considerably faster through HT1080 cells than the parental virus. In the following set of experiments, we addressed the questions if the enhanced spreading is MMP dependent and if this is because of enhanced cell entry. In the first experiment the target cells were pretreated with the broad range MMP inhibitor GM6001 (Calbiochem) before infection. This reduced the titres of both, the E-MMP-A and the E-26-A virus by more than 90%, while the infectivity of the unmodified wild-type MLV remained largely unchanged (Figure 6a) . Thus, the selected virus E-26-A had retained the dependence on MMP-activation to a similar degree as the parental virus. Next, we assayed the cell entry kinetics of both viruses. For this, RT units of stock viruses were determined and equivalent amounts of virus particles incubated with HT1080 cells for different time periods. Then, cells were washed and GM6001 was added to prevent entry of any virus particles being attached to but not yet internalized by the cells. After 4 h, the RT inhibitor AZT was added to Figure 6b shows the results of this experiment. While the cell entry efficiencies were similar when more than 10 min were allowed for cell entry, strong differences were observed for the short incubation periods. Within 1 min more than 10-fold more particles of the selected virus type had entered HT1080 cells. This experiment demonstrates that the enhanced spreading ability of the selected viruses is due to an enhanced cell entry kinetic.
Finally, we determined the virus infectivity on A431 cells that express high levels of EGF receptor but considerably lower amounts of MMP-2 than HT1080 cells. 11 Again equivalent RT units of the E-MMP-A and the E-26-A virus were used to infect A431 and in parallel also HT1080 cells. Both viruses were strongly reduced in their ability to infect A431 cells and remained more than 10-fold below their infectivites on HT1080 cells ( Figure  6c) . However, pretreatment with MMP-2 increased the virus titres on A431 cells considerably, especially in case of the E-26-A virus for which about half the infectivity observed on HT1080 cells could then be reached. Thus, taken together this set of experiments demonstrates that the selected virus retains the tropism and the MMP dependence of the parental virus but is greatly improved in its cell entry kinetic.
Discussion
The data presented here demonstrate that libraries of EGF displaying MLVs diversified in the amino-acid residues of their linker peptides can be used to evolve MMP-activatable retroviruses with enhanced spreading capabilities. While molecular evolution from phage display libraries has become an established approach for the optimization of enzymatic activities or proteinprotein interactions molecular evolution of retroviruses still is in a very early stage. In fact, since the initial proof of principal for the generation and selection of retroviral display libraries, 10 only two reports described the selection of retroviruses with altered host range from libraries of diversified Env proteins. 22, 23 Two modifications of our first-generation libraries were instrumental for the successful selections. First, the selection protocol was modified such that the librarytransfected cells were expanded for several days before the selective pressure was increased by diluting the transfected cells with uninfected cells. Second, key residues within a well-established MMP substrate peptide were diversified using doped degenerated codons thereby excluding arginine residues from the substrate peptides. Although this eliminated a few further aminoacid residues from the linker peptides, we were thereby able to overcome the previously observed dominant activity of furin-like proteases and PCs on the MLV Env protein export pathway. 10 For future applications, however, it will be possible to eliminate arginine codons exclusively using oligonucleotides based on dimerphosphoramidites. 24 By only two consecutive cycles of diversification and selection, MMP-activatable viruses were obtained that were able to spread through HT1080 cells with a greatly enhanced spreading kinetic. Although they grew within the same time frame to up to 10 3 -fold higher titres than the parental virus, they had retained the MMP-dependent tropism. Two amino-acid exchanges in the parental PLGkLWA linker peptide, glutamine in P2 and tyrosine or phenylalanine in P2 0 , were crucial for this phenotype. The PLGkLWA peptide has been widely used as efficient substrate for many different types of MMPs not only as isolated substrate peptide but also in the context of MMP-activatable therapeutics making its substantial improvement by our approach even more remarkable. 19, 25 Generally, it is conceivable that during the in vivo selection process a number of different molecular parameters determine which linker peptide mediates survival of the fittest virus clone. Our biochemical analysis identified two parameters that had improved during selection. First, the selected PQGLYQ peptide was cleaved with a significantly higher turnover rate than the parental PLGkLWA peptide. Second, enhanced particle incorporation rates of the Env proteins displayed via the 
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RM Schneider et al PQGLYQ or the PQGLYA peptide were observed. The latter observation was unexpected. The enhanced particle incorporation, however, correlated with an increase in cell surface expression. It is therefore likely, that the observed effect on incorporation is basically because of an improved folding and cell surface transport of the selected Env proteins. In fact, our Western blot analysis demonstrated that the relative levels of processed Env protein versus the Env protein precursor are raised in cells infected with the selected viruses, while the cell surface transport of the parental virus Env protein seems to be impaired. However, there are different lines of evidence implying that the selected linker peptides are primarily protease substrates mediating enhanced proteolytic sensitivity while the improved incorporation rates are rather a side effect. First, Env incorporation differed by almost three-fold between the two selected viruses that were analysed, yet both viruses spread equally well in HT1080 cells. Furthermore, the E-A virus displaying a noncleavable linker showed a similarly high incorporation rate as the selcted viruses but was unable to propagate in HT1080 cells. Second, and in line with this, it was demonstrated previously that a surprisingly low threshold level of Env molecules per MLV particle exists, above which a large excess of Env can be incorporated without any improvement for infectivity. 26 Third, when the linker peptide was transferred into the context of the CD40L blocking domain, it was again much more efficiently cleaved by MMP-2 than the parental peptide in the same context, but did not alter the incorporation efficiency. Thus, enhanced susceptibility towards MMP-2 is a universal property of the selected linker peptide, whereas enhanced Env incorporation seems to be a context-dependent phenomenon. Finally, when furinactivatable viruses were selected from completely randomized linker peptide libraries totally different aminoacid motifs were obtained but an influence on the Env incorporation rates was not detectable. 10 Given that proteolytic cleavage was the main driving force of selection, this can principally not only occur upon virus cell entry but also upon the release of particles. Indeed, partial cleavage of the EGF domain was detectable in particles released from HT1080 cells, thus presumably facilitating their entry into the neighbouring cell. However, the release of E-26-A virus particles from infected HT1080 cells was unaffected upon treatment with the MMP inhibitor GM6001 (not shown). In contrast, the influence of MMP activation on cell entry was clearly detectable. When we incubated HT1080 cells with both types of viruses for very short incubation periods, we observed 10-fold more cell entry events for the selected virus than for the parental virus. This enhanced cell entry kinetic correlates perfectly well with the enhanced turnover rate of the selected peptide we observed in the MMP-2 cleavage assays. An improved activatability of the selected E-26-A virus was further confirmed in infection assays on A431 cells which required the addition of exogenous MMP-2 to allow cell entry. Thus, the data we have collected suggest that although both events may play a role in the spreading of MMP-activatable viruses, proteolytic activation upon cell entry is the parameter that makes the selected viruses superior to the parental virus. It must therefore have been the key driving force of the selection process. It should also be mentioned that many MMPs have overlapping substrate recognition profiles and HT1080 cells are known to express besides MMP-2, also MMP-1, -7 and, at their cell surface, MT1-MMP. 19, 27 Based on their substrate preferences, as determined using phage protease substrate libraries, especially the linker peptides of the P-X-XkHy type (Hy: large hydrophobic) selected from our libraries are likely to form an optimal substrate not only for MMP-2 but also the other MMPs listed above. In contrast, the linker peptides fulfilling the L/I-X-XkHy consensus are most likely specific MMP-2 substrates. 28 The immediate application of the system presented here lies in the design and optimization of MMPactivatable therapeutics including not only proteaseactivatable retroviral vectors but also MMP-activatable tumour toxins. 25 For both, efficient cleavage by the proteases expressed by the tumour cell is a key parameter that can be optimized with our system under physiological conditions. Beyond that, the conditionally replicating retroviruses selected from protease substrate libraries might directly be used to design antitumoural viruses. For this, a strict tropism for tumour tissue and the insertion of therapeutic genes will be required. The viruses generated by our approach show a considerably increased spreading efficiency through tumour cells, but yet depend on the proteases active at sites of tumour invasion and had the tropism of the parental virus retained. The fact that the EGF blocking domain was partially cleaved off from particles released from HT1080 cells may only be seen as an obstacle at first glance. Even if the residual EGF displaying Env proteins are not sufficient to block cell entry, and the virus will therefore enter protease-negative nontumour cells, further spreading into the protease-negative tissue will be limited, as the protease-negative cells will release blocked virus. Moreover, alternative blocking domains like CD40 ligand eventually allowing a more strict control of the viral biodistribution can be tested and cleavage sites optimally working in their context can be selected from the corresponding libraries. 5, 29 The option to insert additional reading frames into the complete MLV genome thus allowing the expression of potential anticancer genes from replication-competent retroviruses has recently become available. 30 Thus, the generation of therapeutic viruses optimally adapted to the proteolytic activities of a given cancer type from individual patients can be envisaged by selecting the libraries on mixed cell populations or even tumour biopsy material.
The possibility of substrate selection under such in vivo like conditions may also be of interest for the rational design of optimal protease inhibitor-based cancer drugs. Only the in vivo selection of retrovirus based libraries takes so many different parameters as listed above into account. This is impossible by rational design but the strength of retrovirus-based libraries which makes them in this respect superior to combinatorial chemical-or phage-based peptide libraries.
Materials and methods
Generation of the plasmids
All plasmids encoding the viruses and virus libraries used in this study were derived from pE-Mo. 10 First, the Ligation and cloning conditions for the libraries were basically as previously described with the exception that ElectroTen-Blue bacterial cells (Stratagene, USA) were used in 0.1 cm cuvettes at 1.7 kV, 200 O, and 25 mF.
10
Electroporated bacteria were plated and subsequently grown up in liquid medium for purification of the plasmid DNA.
Cell culture
The HT1080 (human fibrosarcoma; ATCC CCL121), A431 (human epidermoid carcinoma; ATCC CRL-1555), and HEK-293T, originally referred to as 293tsA1609neo (human kidney epithelia) 31 cell lines, were grown in Dubellcós modified Eagle's medium (DMEM; Gibco-BRL, UK) supplemented with 10% fetal calf serum (FCS; Gibco-BRL, UK), bezylpenicillin (60 mg/ml), and streptomycin (100 mg/ml), at 371C in an atmosphere of 5% CO 2 .
Selection of the virus libraries
Two wells of a six-well dish each containing 4 Â 10 5 HT1080 cells were transfected with 3 mg plasmid library per well using Lipofectamine Plus (GIBCO-BRL, UK) according to the suppliers instructions. The cells were grown to confluency, and then transferred to a T75 culture flask on day 2 after transfection. The cells were expanded until day 8 when 20% of the cells were removed and mixed with an equal amount of uninfected HT1080 cells. Every 2-3 days supernatant of the cells was analysed for RT activity. On day 14 after transfection, when RT activity had significantly increased, virus was collected from the cell supernatant by ultracentrifugation in a SW41 rotor (Beckman, USA) at 30 000 rpm for 1 h at 41C and RNA was purified using the QIAamp Viral RNA Mini Kit (Qiagen, Germany) followed by treatment with DNase (Promega, USA).
For sequence analysis, RNA was reverse transcribed into cDNA (primer CB27 5 0 -CTGTTCCTGTCCGGTA CAGTC-3 0 ), which was then amplified by PCR using CB6 (+)5 0 -CCCCTAATCCCCTTAATTCTTC-3 0 and EAseq1 (À)5 0 -TATAATTTTGGGAAGGCATCTTG-3 0 . The PCR products were subcloned using the Topo-TA cloning kit (Invitrogen, Netherlands) and plasmid from single bacterial colonies was sequenced using the primer CB26-DW (+)5 0 -CAATAGTGACTCTGAATGTCC-3 0 .
Virus stocks and titration
To generate virus stocks 50-70% confluent HEK-293T cells grown in T175 flasks were transfected with 28 mg viral plasmid DNA using Lipofectamine Plus (Gibco-BRL, UK). At 2 days after transfection, virus-containing supernatants were filtered through a 0.45 mm sterile filter and aliquots were stored at À801C. The cells were further cultivated in serum-free DMEM overnight and viral supernatants were harvested as before. Infectious particles released from HT1080 or HEK-293T cells were quantified by immunohistochemistry using the goat anti RLV-p30 serum (Quality, Biotech), as previously described. 10 RT activity was determined using the C-type-RT Activity Assay (Cavidi Tech, Sweden) according to the manufacturers instructions.
Western blot analysis and proteolytic digestion
For Western blot analysis, virus particles were harvested into serum-free medium and then concentrated by ultracentrifugation at 30 000 rpm for 1 h at 41C in an SW41 rotor (Beckman, USA). Virus collected from 11 ml supernatant was then suspended in 100 ml of cold PBS and stored at À801C till further analysis. Optionally, viral proteins were deglycosylated with PNGase F (New England Biolabs, USA), and then separated by electrophoresis on a 10% SDS-polyacrylamide gel, electrotransferred onto nitrocellulose membrane (Hybond ECL, Amersham Life Science, UK) and then incubated with the goat anti-RLV-gp70 or anti-RLV-p30 sera (Quality, Biotech). For visualization of the antigen/antibody complexes, horseradish peroxidase (HRP)-conjugated rabbit anti-goat antibodies (DAKO, Denmark) and the chemiluminescence kit SuperSignal (Pierce, USA) were used.
The incorporation rates of selected viruses were determined by scanning densitometry using Quantity One analysis software (Bio-Rad, Germany). The optical densities of the p30 and SU signals were measured and the ratios of SU to p30 calculated.
For the MMP-2 cleavage in vitro, 20 ml of pelleted virus was incubated with 0.5 mg of activated MMP-2 (Chemicon, USA) in a final volume of 25 ml for the indicated time periods at 371C. The proteins were then separated by electrophoresis and immunoblotted as described above. For proteolytic activation in vivo, 30 ml of virus containing serum-free cell culture supernatant was incubated with Directed evolution of targeted retroviruses RM Schneider et al 0.5 mg activated MMP-2 enzyme or as a control with MMP-2 buffer alone in a final volume of 35 ml for 1 h at 371C. For infection, A431 cells were seeded in a 24-well plate at a density of approximately 5 Â 10 4 per well. On the next day, MMP-2-treated virus was added in a final volume of 250 ml serum-free DMEM for 1 h at 371C. After 20 h, infected cells were determined by immunohistochemistry.
Surface expression of viral Env proteins
Surface expression efficiency of viral Env proteins was determined by fluorescence-activated cell sorting (FACS). For this, Env protein expression plasmids based on plasmid pFBSALF 32 were constructed. The HEK-293T cells (5 Â 10 5 ) were seeded overnight at 371C in a six-well culture plate. The cells were cotransfected by using Lipofectamine Plus (GIBCO-BRL, UK) according to the supplier's instructions with 1.5 mg pMFGnlsLacZ 33 encoding beta-galactosidase serving as reporter for transfection efficiency and 1.5 mg of the expression plasmids pFBEASALF, pFBEMMPASALF, pFBE21ASALF, and pFBE26ASALF, respectivley. After transfection cells were grown for 48 h at 371C. For FACS analysis, 5 Â 10 5 cells were incubated with mouse monoclonal anti-human EGF antibody clone EGF-10 (Sigma, USA) diluted 1 : 100 in washing buffer (2% FCS, 0.01% NaN 3, in PBS) for 30 min at 41C. After washing cells were incubated with antimouse antibody conjugated with R-phycoerythrin for 30 min at 41C, washed again, and fixed in PBS-1% paraformaldehyde. EGF-positive cells were counted with DAKO Galaxy (DAKO, Germany) and the mean fluorescence intensities were analysed using FlowMax software.
MMP inhibition and cell entry kinetic
HT1080 cells (1 Â 10 5 ) were seeded one day before infection into a 24-well dish in DMEM containing of the MMP inhibitor GM6001 (Calbiochem, USA) or the control substance GM6001, negative control (Calbiochem, USA) at a concentration of 10 mM, respectively. Cells were incubated with virus at an MOI of 0.5 for 4 h at 371C in the presence of GM6001 or the GM6001, negative control. Then, cells were washed with PBS and further cultivated for 30 h before the number of infected cells was determined by immunohistochemistry. 10 For the cell entry kinetic assay, HT1080 cells suspended in DMEM, were seeded overnight at 371C in a 24-well culture plate at a density of approximately 1 Â 10 5 per well. On the next day, cells were washed once with PBS and were then incubated with the viruses (140 mU of RT-activity) in a final volume of 250 ml serumfree DMEM for different time periods. Then, the viruscontaining medium was removed, cells were washed once with PBS and 1 ml DMEM containing 10 mM GM6001 was added. After 4 h, spreading of virus from infected cells to neighbouring cells was prohibited by adding of the RT inhibitor AZT (3 0 -azido-3 0 -deoxythymidine triphosphate; Sigma, Germany) at 10 mM concentration. Finally, the cells were fixed 20 h postinfection and the number of infected cells, which corresponds to the number of cell entry events, was determined by immunohistochemistry as described above.
